Vascular Type of Ehlers–Danlos Syndrome – a Rare Monogenic Connective Tissue Disease

The Ehlers-Danlos syndrome is a rare (orphan) disease characterized by the connective tissue dysplasia, fragility of the blood vessels and tissues, and variable clinical pattern. The vascular type of Ehlers-Danlos syndrome, which belongs to Group A according to the classification of 2017, is caused by the mutations in gene of alpha-1 chain of type III collagen COL3A1. The disease is characterized by the high mortality rate of the patients due to the spontaneous ruptures of the vascular walls and hollow viscera. The International Consortium (2017) developed the criteria for the clinical diagnosis of the vascular type of Ehlers – Danlos syndrome.
The clinical case of the 16-year-old male patient with vascular type of Ehlers – Danlos syndrome is presented. The molecular genetic testing revealed in the child the previously described pathogenic mutation of splice site p.Gly798_Pro815del of COL3A1 gene associated with the severe course of the disease. In spite of the set of therapy measures aimed at the vascular reinforcement, stimulation and normalization of energy and mineral metabolism, the death occurred in 10 months due to the rupture of the aorta and renal artery. The Conclusion of the forensic medical examination is presented. The results of the care presented indicate that in order to avoid the omission of patients, it is advisable to revise the minimum set of signs required for the clinical diagnosis.

1. Malfait F., Francomano C., Byers P., Belmont J., Berglund B., Black J. et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175(1): 8–26. DOI: 10.1002/ajmg.c.31552

2. Germain D.P. Ehlers–Danlos syndrome type IV. Orphanet J Rare Dis 2007; 2:32. DOI: 10.1186/1750-1172-2-32

3. Eagleton M.J. Arterial complications of vascular Ehlers–Danlos syndrome. J Vasc Surg 2016; 64(6): 1869–1880. DOI: 10.1016/j.jvs.2016.06.120

4. Papagiannis J. Sudden death due to aortic pathology. Cardiol Young 2017; 27(S1): S36–S42. DOI: 10.1017/S1047951116002213

5. Legrand A., Devriese M., Dupuis-Girod S., Simian C., Venisse A., Mazzella J.M. et al. Frequency of de novo variants and parental mosaicism in vascular Ehlers–Danlos syndrome. Genet Med 2019; 21(7): 1568–1575. DOI: 10.1038/s41436-018-0356-2

6. Shields L.B.E., Rolf C.M., Davis G.J., Hunsaker J.C. Sudden and unexpected death in three cases of Ehlers–Danlos syndrome type IV. Case Reports. J Forensic Sci 2010; 55(6): 1641–5. DOI: 10.1111/j.1556-4029.2010.01521.x

7. Park M.A., Shin S.Y., Kim Y.J., Park M.J., Lee S.H. Vascular Ehlers–Danlos syndrome with cryptorchidism, recurrent pneumothorax, and pulmonary capillary hemangiomatosis-like foci: A case report. Medicine (Baltimore) 2017; 96(47): e8853. DOI: 10.1097/MD.0000000000008853

8. Park K.Y., Gill K.G., Kohler J.E. Intestinal Perforation in Children as an Important Differential Diagnosis of Vascular Ehlers–Danlos Syndrome. Am J Case Rep 2019; 20: 1057–1062. DOI: 10.12659/AJCR.917245

9. D’hondt S., Van Damme T., Malfait F. Vascular phenotypes in nonvascular subtypes of the Ehlers–Danlos syndrome: a systematic review. Genet Med 2018; 20(6): 562–573. DOI: 10.1038/gim.2017.138